Clinical trial

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

NCT01051960

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE4

Study timeline

Study start (actual)2009-03-01Date precision: month

Registry last updated2020-11-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Systemic Sclerosisunresolved

Shortness of Breathunresolved

Pulmonary Hypertensionunresolved

Interventions

AmbrisentanDRUG · verified · RxNorm: ambrisentan

Sponsors & collaborators

University of California, Los Angeleslead sponsor

Gilead Sciencescollaborator

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01051960 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.